Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Alligator Bioscience AB. (3/31/11). "Press Release: Alligator Bioscience AB Raises 43 MSEK in Directed New Share Issue".

Organisations Organisation Alligator Bioscience AB (Nasdaq Stockholm: ATORX)
  Group Alligator Bioscience (Group)
  Organisation 2 Sunstone Capital A/S
  Today Sunstone Life Science Ventures A/S
  Group Sunstone Life Science (Group)
Products Product BIOTECH
  Product 2 venture capital
Index term Index term Alligator Bioscience–SEVERAL: investment, 201103 financing round SEK43m directed new share issue lead investor Sunstone Capital SEK12/share

Alligator Bioscience AB has raised 43 MSEK in a new round of equity financing. Mainly new institutional investors participated in the financing. The larger part was invested by the Nordic venture capital investor Sunstone Capital. Price per share in the directed new share issue was 12 SEK per share.

Alligator Bioscience AB intends to do a share issue to current owners with the same price, 12 SEK per share, later this spring. Prospectus and terms will be published in May.

If you have any questions please contact

Dr Sibylle Lenz
CEO of Alligator Bioscience AB,
+46 (0)46 286 42 80.

Record changed: 2015-08-10


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Alligator Bioscience (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnering Forum 2020 Digital Event CBPF2020 650x80

» top